Literature DB >> 23382407

Imbalance of renal production between 5-hydroxytryptamine and dopamine in patients with essential hypertension complicated by microalbuminuria.

Masayo Hirose1, Fumihiro Tomoda, Tsutomu Koike, Hidenori Yamazaki, Maiko Ohara, Hexing Liu, Satoshi Kagitani, Hiroshi Inoue.   

Abstract

BACKGROUND: In the kidney, 5-hydroxytryptamine (5-HT) and dopamine (DA) are formed by the same enzyme, l-aromatic amino acid decarboxylase, but act on renal function and glomerular structure in an opposite direction. The present study was designed to explore whether rates of renal production of 5-HT relative to that of DA are altered in patients with essential hypertension and microalbuminuria.
METHODS: We measured urinary levels of 5-HT and DA, reflecting renal production of 5-HT and DA as well as 24-hour ambulatory blood pressure and urinary albumin excretion in 82 consecutive untreated, essential hypertensives without overt proteinuria.
RESULTS: Urinary 5-HT excretion and the ratio of urinary 5-HT to DA were significantly higher in 22 patients with microalbuminuria than in the remaining patients with normoalbuminuria, although urinary DA levels did not differ between the groups. The 24-hour systolic and diastolic blood pressures were also higher in the microalbuminuric group than in the normoalbuminuric group. Multiple regression analysis revealed that urinary 5-HT excretion and 24-hour systolic blood pressure were independently associated with urinary albumin excretion. Furthermore, urinary 5-HT excretion was positively correlated with creatinine clearance as well as blood pressure but tended to be negatively correlated with fractional excretion of sodium.
CONCLUSIONS: Renal production of 5-HT is enhanced compared with that of DA in essential hypertensives with microalbuminuria. This imbalance may contribute to the genesis of hypertensive glomerular damage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23382407     DOI: 10.1093/ajh/hps008

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  5 in total

1.  Serotonin and dopamine in essential hypertension.

Authors:  Charles T Stier
Journal:  Am J Hypertens       Date:  2012-12-28       Impact factor: 2.689

2.  A HPLC-Q-TOF-MS-based urinary metabolomic approach to identification of potential biomarkers of metabolic syndrome.

Authors:  Zhi-Rui Yu; Yu Ning; Hao Yu; Nai-Jun Tang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-04-08

3.  Active Acupoints Differ from Inactive Acupoints in Modulating Key Plasmatic Metabolites of Hypertension: A Targeted Metabolomics Study.

Authors:  Mingxiao Yang; Zheng Yu; Xiaomin Chen; Zhenyu Guo; Shufang Deng; Lin Chen; Qiaofeng Wu; Fanrong Liang
Journal:  Sci Rep       Date:  2018-12-13       Impact factor: 4.379

4.  A Targeted Metabolomics MRM-MS Study on Identifying Potential Hypertension Biomarkers in Human Plasma and Evaluating Acupuncture Effects.

Authors:  Mingxiao Yang; Zheng Yu; Shufang Deng; Xiaomin Chen; Liang Chen; Zhenyu Guo; Hui Zheng; Lin Chen; Dingjun Cai; Bo Wen; Qiaofeng Wu; Fanrong Liang
Journal:  Sci Rep       Date:  2016-05-16       Impact factor: 4.379

5.  Monoamino oxidase alleles correlate with the presence of essential hypertension among hypogonadic patients.

Authors:  José Luis Royo; Daniel Castellano-Castillo; Maximiliano Ruiz-Galdon; María Molina-Vega; Fernando Cardona; Francisco J Tinahones; José C Fernández-García; Armando Reyes-Engel
Journal:  Mol Genet Genomic Med       Date:  2019-11-19       Impact factor: 2.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.